Migraine Treatment and Prophylaxis
Acute Treatment
For most migraine sufferers, NSAIDs are first-line therapy, with aspirin, ibuprofen, or naproxen sodium showing the most consistent evidence. 1
First-Line Acute Treatment Algorithm
- Start with NSAIDs (aspirin, ibuprofen, naproxen sodium) or the combination of acetaminophen plus aspirin plus caffeine for initial attacks 1
- Acetaminophen alone has no evidence for efficacy and should not be used 1
- Treat early in the attack to maximize effectiveness 1
Second-Line: Migraine-Specific Agents
- If NSAIDs fail, escalate to triptans or DHE 1
- Evidence-based triptans include: oral sumatriptan, rizatriptan, zolmitriptan, and naratriptan; subcutaneous sumatriptan; and DHE nasal spray 1
- If one triptan fails, try another triptan or combine an NSAID with a triptan 1
- Sumatriptan works through 5-HT1B/1D receptor agonism, causing cranial vessel constriction and inhibiting pro-inflammatory neuropeptide release 2
Special Considerations for Acute Treatment
- Use non-oral routes (nasal spray, subcutaneous) when nausea or vomiting presents early 1
- Add antiemetics for nausea even without vomiting, as nausea itself is disabling 1
- Avoid opioids and butalbital-containing compounds except as absolute last resort due to risk of medication overuse headache 3
Emergency/Intractable Migraine
- IV metoclopramide 10 mg plus IV ketorolac 30 mg is the most effective parenteral combination for severe migraine requiring emergency treatment 3
Prophylactic Treatment
Preventive therapy should be initiated when patients have ≥2 attacks per month producing disability lasting ≥3 days, or when acute medications are used more than twice weekly. 1
Indications for Prophylaxis
- Two or more disabling attacks per month lasting ≥3 days 1
- Contraindication to or failure of acute treatments 1
- Use of abortive medication more than twice per week 1
- Uncommon migraine conditions (hemiplegic migraine, prolonged aura, migrainous infarction) 1
First-Line Prophylactic Agents
Beta-blockers (propranolol 80-240 mg/d, timolol 20-30 mg/d, metoprolol, atenolol, bisoprolol), topiramate, or candesartan are first-line options. 1
- Propranolol: 80-240 mg/d 1
- Timolol: 20-30 mg/d 1
- Topiramate: dose titrated to effect 1
- Candesartan: evidence-based alternative 1
Second-Line Prophylactic Agents
- Amitriptyline 30-150 mg/d 1
- Flunarizine (where available) 1
- Divalproex sodium 500-1500 mg/d or sodium valproate 800-1500 mg/d 1
Third-Line: CGRP Monoclonal Antibodies
- Erenumab, fremanezumab, galcanezumab, and eptinezumab are FDA-approved for migraine prevention 1
- Reserved for patients who have failed other preventive drugs or have contraindications 1
- Assess efficacy only after 3-6 months of treatment 1
Chronic Migraine (≥15 headache days/month)
- OnabotulinumtoxinA 155 units is the only FDA-approved therapy specifically for chronic migraine prophylaxis 1, 3
- Assess efficacy after 6-9 months 1
- Topiramate has proven efficacy in randomized controlled trials for chronic migraine 1
Treatment Principles and Monitoring
Dosing and Duration
- Start with low doses and titrate slowly to minimize adverse effects 1
- Allow 2-3 months to assess efficacy of oral preventive medications before declaring failure 1, 3
- Consider pausing preventive therapy after 6-12 months of successful treatment to determine if it can be discontinued 1
Medication Overuse Headache
- Rule out medication overuse headache if acute medications are used >2 days per week 3
- This creates a vicious cycle requiring withdrawal rather than escalation 3
- Excessive acute medication intake is itself a strong indication for preventive therapy 1
Patient Education and Monitoring
- Use headache diaries to track attack frequency, severity, duration, disability, and medication response 1
- Educate patients that preventive therapy efficacy takes weeks to months 1
- Calculate percentage reduction in monthly migraine days to quantify success 1
Non-Pharmacological Approaches
- Cognitive-behavioral therapy (CBT) and biofeedback have evidence for efficacy 1, 3
- Exercise (40 minutes three times weekly) is as effective as topiramate or relaxation therapy 3
- Non-invasive neuromodulatory devices have supporting evidence 1
- Acupuncture may be beneficial, though not superior to sham acupuncture 1
- Little to no evidence exists for physical therapy, spinal manipulation, or dietary approaches 1
Special Populations
Children and Adolescents
- Ibuprofen is first-line for acute treatment 1
- In adolescents, consider sumatriptan/naproxen oral, zolmitriptan nasal, sumatriptan nasal, rizatriptan ODT, or almotriptan oral 1
- Discuss with families that placebo was as effective as studied medications in many pediatric preventive trials 1
- Consider amitriptyline combined with CBT, topiramate, or propranolol for prevention 1
Pregnancy and Breastfeeding
- Discuss maternal disability versus fetal/neonatal risks when considering pharmacologic treatment 3
- Many standard prophylactic agents have contraindications or require careful risk-benefit analysis 3
Common Pitfalls
- Failure of one preventive class does not predict failure of others (except when due to poor adherence) 1
- Poor adherence is common; simplified once-daily dosing improves compliance 1
- Avoid escalating treatment without first ruling out medication overuse headache 3
- Do not abandon preventive therapy prematurely—efficacy requires adequate trial duration 1